Have breakfast with top biopharma newsmakers

Event Details

Turning Point: Access and Affordability in a New Era of Medicine

2017 is shaping up as a potential turning point in the public debate over drug affordability and access in the United Sates. Should companies self-regulate on pricing, as some have discussed? Should biopharma fight every new proposal? How will the debate influence the companies researching new drugs in the pipeline? We’ll hear from these biopharma CEOs and leaders how they plan to deliver innovative therapies in this new era.


Brent Saunders
CEO, Allergan

Joaquin Duato
EVP and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

Richard Pops
CEO, Alkermes

Stephen Ubl

Steven Pearson

John Carroll
Editor, Endpoints News

Exclusive Sponsor